Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

LGND Financial Statements and Analysis

NASDAQ : LGND

Ligand Pharmaceuticals Incorporated

$119.99
-0.01-0.01%
At Close 4:00 PM
73.75
B-ESG ScoreESG Rating

LGND FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

LGND Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
revenue51.812M41.531M30.978M28.101M32.868M
cost of revenue12.495M11.163M11.068M1.664M3.485M
gross profit39.317M30.368M19.91M26.437M29.383M
gross profit ratio0.7590.7310.6430.9410.894
research and development expenses5.675M5.354M5.971M5.488M5.532M
general and administrative expenses24.475M17.623M10.951M15.992M14.656M
selling and marketing expenses01.50M000
selling general and administrative expenses24.475M19.123M10.951M15.992M14.656M
other expenses6.024M1.50M-2.388M-8.315M-4.30M
operating expenses36.174M22.977M16.922M29.795M28.426M
cost and expenses48.669M34.14M27.99M31.459M31.911M
interest income1.347M2.757M2.02M1.562M2.262M
interest expense741.00K1.268M141.00K131.00K-1.00K
depreciation and amortization8.994M9.357M9.243M8.921M8.238M
ebitda3.143M-54.765M12.231M9.874M23.458M
ebitda ratio0.0610.4030.3950.3510.714
operating income3.143M7.391M2.988M-3.358M-122.00K
operating income ratio0.0610.1780.096-0.119-0.004
total other income expenses net-9.482M-46.29M110.459M20.455M-18.563M
income before tax-6.339M-65.39M113.447M17.097M-15.344M
income before tax ratio-0.122-1.5743.6620.608-0.467
income tax expense833.00K-13.479M27.308M-1.091M-2.552M
net income-7.172M-51.911M86.139M18.188M-12.792M
net income ratio-0.138-1.252.7810.647-0.389
eps-0.39-2.884.861.04-0.74
eps diluted-0.39-2.884.751.03-0.74
weighted average shs out18.419M18.028M17.732M17.466M17.38M
weighted average shs out dil18.419M18.028M18.122M17.676M17.38M
Graph

LGND Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
cash and cash equivalents63.619M18.139M50.093M22.954M19.275M
short term investments156.024M208.793M260.50M147.355M171.227M
cash and short term investments219.643M226.932M310.593M170.309M190.502M
net receivables34.318M37.481M28.435M39.312M39.187M
inventory13.44M20.708M21.337M23.969M25.392M
other current assets41.987M31.338M8.548M3.839M2.68M
total current assets309.388M312.259M368.913M237.429M257.761M
property plant equipment net25.191M25.458M24.382M9.455M9.801M
goodwill105.25M105.25M105.25M103.37M418.613M
intangible assets274.905M283.162M291.42M366.897M6.602M
goodwill and intangible assets380.155M388.412M396.67M470.267M425.215M
long term investments212.404M47.683M46.969M48.321M47.163M
tax assets78.00K190.00K50.606M46.062M8.53M
other non current assets27.65M92.403M26.329M21.53M20.74M
total non current assets645.478M554.146M544.956M595.635M511.449M
other assets00000
total assets954.866M866.405M913.869M833.064M769.21M
account payables4.694M1.793M1.893M14.894M13.11M
short term debt1.09M2.336M1.003M410.00K497.00K
tax payables2.108M2.091M1.138M04.343M
deferred revenue1.152M1.196M1.227M1.222M4.343M
other current liabilities15.728M11.149M12.557M256.00K916.00K
total current liabilities24.772M18.565M17.818M16.782M18.866M
long term debt6.267M6.415M5.191M5.755M5.832M
deferred revenue non current02.696M3.065M15.144M0
deferred tax liabilities non current46.404M30.128M50.606M77.47M31.925M
other non current liabilities36.245M33.403M30.668M15.556M47.185M
total non current liabilities88.916M72.642M89.53M113.925M84.942M
other liabilities00000
capital lease obligations7.357M6.415M5.191M5.755M6.329M
total liabilities113.688M91.207M107.348M130.707M103.808M
preferred stock00000
common stock19.00K19.00K18.00K18.00K18.00K
retained earnings530.072M537.244M589.155M503.016M484.828M
accumulated other comprehensive income loss1.746M-935.00K-910.00K-817.00K-944.00K
other total stockholders equity309.341M238.87M218.258M198.696M181.50M
total stockholders equity841.178M775.198M806.521M700.913M665.402M
total equity841.178M775.198M806.521M700.913M665.402M
total liabilities and stockholders equity954.866M866.405M913.869M833.064M769.21M
minority interest00000
total investments368.428M256.476M307.469M195.676M204.324M
total debt7.357M7.583M6.194M6.165M6.329M
net debt-56.262M-10.556M-43.899M-16.789M-12.946M
Graph

LGND Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
deferred income tax-1.988M-20.666M19.546M4.935M8.007M
stock based compensation26.231M11.06M7.334M5.721M6.884M
change in working capital-633.00K-7.61M8.243M-15.991M-20.832M
accounts receivables4.793M-9.049M3.462M2.835M-7.912M
inventory1.932M2.489M2.632M707.00K-611.00K
accounts payables2.227M1.772M-1.382M1.839M-1.583M
other working capital-709.00K-2.822M3.531M-21.372M-10.726M
other non cash items12.903M107.589M-90.706M-13.709M15.318M
net cash provided by operating activities36.628M13.257M18.691M8.065M7.646M
investments in property plant and equipment3.578M-2.139M-105.00K-50.745M-487.00K
acquisitions net-91.996M-75.00M-998.00K-14.00K-25.64M
purchases of investments-4.768M-24.441M-77.634M-19.502M-18.273M
sales maturities of investments94.795M47.056M75.463M59.908M24.761M
other investing activites-48.116M-75.235M-501.00K69.00K136.00K
net cash used for investing activites-46.507M-54.759M-3.775M-10.284M-19.503M
debt repayment-10.00K-4.00K-5.00K-45.00K0
common stock issued-24.856M9.552M15.304M6.526M7.574M
common stock repurchased00-3.076M00
dividends paid00000
other financing activites79.848M-57.00K-3.076M-1.166M-4.304M
net cash used provided by financing activities54.982M9.548M12.223M5.315M3.27M
effect of forex changes on cash377.00K00583.00K14.301M
net change in cash45.48M-31.954M27.139M3.096M-8.587M
cash at end of period63.619M18.139M50.093M22.954M19.858M
cash at beginning of period18.139M50.093M22.954M19.858M28.445M
operating cashflow36.628M13.257M18.691M8.065M7.646M
capital expenditure3.578M-2.139M-105.00K-50.745M-487.00K
free cash flow40.206M11.118M18.586M-42.68M7.159M
Graph

Frequently Asked Questions

How did Ligand Pharmaceuticals Incorporated do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, LGND generated $51.81M in revenue last quarter, while its costs came in at $12.50M.

Last quarter, how much Gross Profit did Ligand Pharmaceuticals Incorporated report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Ligand Pharmaceuticals Incorporated reported a $39.32M Gross Profit for the quarter ended Sep 30, 2024.

Have LGND's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. LGND incurred $36.17M worth of Operating Expenses, while it generated $3.14M worth of Operating Income.

How much Net Income has LGND posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Ligand Pharmaceuticals Incorporated, the company generated -$7.17M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did Ligand Pharmaceuticals Incorporated have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Ligand Pharmaceuticals Incorporated as of the end of the last quarter was $63.62M.

What are LGND's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, LGND had Total Net Receivables of $34.32M.

In terms of Total Assets and Current Assets, where did Ligand Pharmaceuticals Incorporated stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of LGND were $309.39M, while the Total Assets stand at $954.87M.

As of the last quarter, how much Total Debt did Ligand Pharmaceuticals Incorporated have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of LGND's debt was $7.36M at the end of the last quarter.

What were LGND's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, LGND reported total liabilities of $113.69M.

How much did LGND's Working Capital change over the last quarter?

Working Capital Change for LGND was -$633.00K over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

LGND generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. LGND generated $36.63M of Cash from Operating Activities during its recently reported quarter.

What was LGND's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. LGND reported a $45.48M Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph